GL1X · GenesisL1 explorer

MolNFT v1 · #138295 · protein

1.95 a resolution structure of norovirus 3CL protease in complex with a dipeptidyl oxazolidinone-based inhibitor

5WEJ · Genome polyprotein: “1.95 a resolution structure of norovirus 3CL protease in complex with a dipeptidyl oxazolidinone-based…”. X-ray diffraction, 1 ligand (V45), 3 pockets (best druggability 0.62). MolNFT v1 #138295 on GenesisL1: 3D…

PDB
5WEJ
Type
protein
Length
334 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Genome polyprotein
EC
3.6.1.15, 3.4.22.66, 2.7.7.48
UniProt
Q83883
Ligands
V45
Pockets
3 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGenome polyprotein (EC 3.6.1.15, 3.4.22.66, 2.7.7.48)protein1726% helix, 49% strandQ83883
BGenome polyprotein (EC 3.6.1.15, 3.4.22.66, 2.7.7.48)protein1626% helix, 54% strandQ83883

Ligands and binding sites

  • V45 · (2S)-2-{(5S)-5-[(3-chlorophenyl)methyl]-2-oxo-1,3-oxazolidin-3-yl}-4-methyl-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}pentanamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13000.620.7940empty
22180.610.8136empty
31380.420.7530V45

Interfaces

1 interface between chains.

  • A–B · 482 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 disulfide (covalent ligand, disulfide).

Compared structures

  • 5WEJ · 1.95 A resolution structure of Norovirus 3CL protease in complex with a dipeptidyl… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.